Regeneron Pharmaceuticals
REGN65
$998.23arrow_drop_down1.02%-$10.29
S&P500
REGN65
$998.23
arrow_drop_down1.02%AI Deep-Learning Forecast (REGN)
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Regeneron Pharmaceuticals (REGN) Stocklytics Forecast
Keep an eye on Regeneron Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the analyst price prediction for Regeneron Pharmaceuticals (REGN) stock?
Analysts have set a target price of $956.76 for Regeneron Pharmaceuticals (REGN), based on forecasts from 29 analysts. The predicted price range extends from a high of $1.11K to a low of $800. This represents a potential increase of up to 11.2% and a decrease of -19.86% from the current price of $998.23. These forecasts are as of 2023 Aug 21.
help
What are the analyst ratings for Regeneron Pharmaceuticals (REGN) stock?
The analyst ratings for Regeneron Pharmaceuticals (REGN) are distributed as follows: 13 analysts recommend buying, 12 have a neutral stance, and 1 suggest selling. The prevailing sentiment among the total of 26 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Regeneron Pharmaceuticals .
help
What is the AI price prediction for Regeneron Pharmaceuticals (REGN) stock?
At present, there is no AI or machine-learning-based price prediction available for Regeneron Pharmaceuticals (REGN) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.